Table 1 Patient information
Patient ID | Age | Sex | Cytogenetics | CD33 (%) | FLT3 (SFI) |
|---|---|---|---|---|---|
1 | 46 | F | FLT3-ITD NPM1 p.W288fs (Exon12) DNMT3A p.r882C (Exon23) PTPN11 p.G60R (Exon3) | 90.5 | 3.03 |
2 | 45 | M | FLT3-ITD | 95.8 | 2.03 |
3 | 34 | F | FLT3-ITD PML-RARα | 97 | 1.78 |
4 | 52 | F | FLT3-ITD NMP1 p.W288fs | 96.32 | 4.87 |
5 | 45 | F | FLT3-ITD PML-RARα | 94.1 | 1.40 |
6 | 46 | F | FLT3-WT DNMT3A p.R882C (Exon23) | 65.5 | 1.49 |
7 | 27 | M | FLT3-WT CBFβ-MYH11 NRAS p.G12D (Exon2) NRAS p.Q61K (Exon3) | 91.2 | 1.94 |
8 | 26 | F | FLT3-WT CBFβ-MYH11 NRAS p.Q61K (Exon3) | 44 | 1.5 |
9 | 19 | F | FLT3-WT CBFβ-MYH11 KIT p.N822K (Exon17) NRAS p.G13D (Exon2) | 66 | 2.65 |
10 | 34 | F | FLT3-WT CBFβ-MYH11 NRAS p.Q61H (Exon3) | 89.6 | 2 |